They talk about us

Highlights

Press release

MedX Health Corp. announces Dr. Paul Cohen as Medical Spokesperson

MISSISSAUGA, ON — January 25, 2024 – MedX Health Corp. (“MedX” or the “Company”) (TSX VENTURE: MDX) is pleased to announce that it has appointed Dr. Paul Cohen, a board-certified dermatologist and Fellow of the Royal College of Physicians and Surgeons of Canada, as Medical Spokesperson. Dr. Cohen is also a diplomat of the American Board of Dermatology and is a member of numerous associations, including the Canadian Dermatological Association and the Toronto Dermatological Society…

 
Press release

May 10, November 14, MedX Health Corp. Announces Closing of Non-brokered Private Placement and Amendment of Terms of Warrants Issued in April, May and July, 2020

Mississauga, ON, November 14, 2023. MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) announced today that, it has submitted for Final Acceptance from the TSXV and has closed the non-brokered Private Placement which was previously announced on August 30, 2023. The placement, to accredited investors, raised $1,020,000 by issuance of 14,571,428 units at $0.07per unit (“Unit”)….

September 1st, TORMONT50 : MedX Health Report

MedX Health Corp., a speculative micro-cap stock with a current equity valuation of just $12 million, has developed its SIAscopeTM, a Class 2 medical scanning device which, used in conjunction with an HD camera, can scan suspicious – potentially cancerous – moles and lesions and penetrate two millimeters (mm) below the surface of the skin to accurately generate high quality images. See Figure 1 and 2. These images are then uploaded to MedX’s proprietary DermSecureTM telemedicine platform to be securely transmitted to dermatologists for assessment

 

 
Press release

May 10, MedX Announces Appointment of Stephen Lockyer as CEO

Stephen, who became a major investor in the company in recent months, and who joined the Board in April, 2023, brings extensive knowledge and years of financial management and entrepreneurial experience, and was instrumental in the introduction of the project with PharmaChoice which has just been launched in Canada,” said Ken McKay, Chairman of the MedX Board of Directors….

 

April 18, MedX Health and PharmaChoice Announce Agreement to Launch MedX Teledermatology Screening Platform Across Canada

MedX Health Corp. (“MedX” or the “Company“) (TSXV: MDX), a global leader in teledermatology, is pleased to announce a Memorandum of Understanding for the launch of a new commercialization pilot project (the “Pilot Project”) with PharmaChoice Canada (“PharmaChoice”), one of Canada’s fastest‐growing pharmacy groups

More Releases
Get In Touch

Our impact is growing daily and our reach is worldwide

If you need more information about our services or our business vision please reach out and we will connect you with the proper member of our team who can serve you best!

1495 Bonhill Road, Unit # 1 Mississauga, ON Canada L5T 1M2
:before
+1 888 363 3112
en_CAEnglish (Canada)